Pathology review identifies frequent misdiagnoses in recurrent classic Hodgkin lymphoma in a nationwide cohort: implications for clinical and epidemiological studies

Patients treated for classic Hodgkin lymphoma (CHL) have a reported 13-fold increased risk of developing subsequent non-Hodgkin lymphoma (NHL). In light of the growing awareness of CHL mimickers, this study re-assesses this risk based on an in-depth pathology review of a nationwide cohort of patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Boot, Max V., Schaapveld, Michael, van den Broek, Esther C., Hijmering, Nathalie J., van der Oord, Kimberly, van Leeuwen, Flora E., Dinmohamed, Avinash G., Koens, Lianne, de Jong, Daphne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2022
Materias:
Article - Hodgkin Lymphoma
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10153541/
https://www.ncbi.nlm.nih.gov/pubmed/36263842
http://dx.doi.org/10.3324/haematol.2022.280840

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10153541/
https://www.ncbi.nlm.nih.gov/pubmed/36263842
http://dx.doi.org/10.3324/haematol.2022.280840

Ejemplares similares